Trials / Completed
CompletedNCT00233389
Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
A Post-marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 301 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To examine the efficacy of continued administration of rebamipide following bacteria eradication therapy in patients with H. pylori-positive active gastric ulcer in a placebo-controlled, double-blind study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rebamipide |
Timeline
- Start date
- 2004-04-30
- Primary completion
- 2005-09-01
- Completion
- 2005-09-09
- First posted
- 2005-10-05
- Last updated
- 2021-06-04
- Results posted
- 2021-06-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00233389. Inclusion in this directory is not an endorsement.